EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Saccharomyces cerevisiae EBY100/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection

Dayue Hu iD, Xiangmin Li iD, Xiaochao Duan, Liuyue Yang, Baizhi Luo, Linkang Wang, Zihui Hu, Yang Zhou, Ping Qian iD

Applied and Environmental Microbiology · 2025

DOI: 10.1128/aem.01817-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied and Environmental Microbiology, 2025. Verfasst von Dayue Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Enterotoxigenic Escherichia coli, Escherichia coli Infections, Escherichia coli Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diarrheal diseases attributable to multidrug-resistant F4+ enterotoxigenic Escherichia coli (ETEC) are escalating in severity, posing significant risks to the health and safety of both humans and animals. This study used Saccharomyces cerevisiae EBY100 to display the FaeG subunit of F4 colonizing factor as an oral vaccine against F4+ ETEC infection. Mice were orally immunized twice with 10 8 CFU of EBY100/pYD1-FaeG, followed by a challenge with F4+ ETEC EC6 on day 7 post-immunization. The results showed that the recombinant strain EBY100/pYD1-FaeG orally enhanced the growth of the small intestine villi, significantly boosted the expression of tight junction proteins ( ZO-1 , Occludin , MUC2 , and Claudin ) ( P < 0.05), and modulated the gut microbiota composition. Additionally, immunization with EBY100/pYD1-FaeG also upregulated the levels of IL-2, IL-4, and IFN-γ in the intestines of mice ( P < 0.01), while serum IgG and fecal sIgA titer significantly increased ( P < 0.05). These immune responses enhanced the capacity to fight against ETEC, leading to an increased survival rate of mice and relieved damage to tissues and organs of mice infection. In summary, the study suggested that the recombinant Saccharomyces cerevisiae EBY100/pYD1-FaeG could effectively stimulate the immune response and generate specific antibodies against F4+ ETEC, showing its potential to serve as a subunit oral vaccine candidate for preventing F4+ ETEC infection. IMPORTANCE The multidrug-resistant F4+ enterotoxigenic Escherichia coli (ETEC) strains are the primary clinical pathogens responsible for post-weaning diarrhea in piglets, resulting in substantial economic losses in the pig farming industry. In the study, we developed an oral vaccine candidate, Saccharomyces cerevisiae EBY100/pYD1-FaeG, to prevent diarrhea caused by multidrug-resistant F4+ ETEC. Oral administration of EBY100/pYD1-FaeG significantly enhanced immune responses, improved intestinal health, and provided protection against F4+ ETEC infection in mice. This approach offers a potential application prospect for preventing F4+ ETEC infections that lead to post-weaning diarrhea in clinical settings and provides a promising solution for addressing the growing threat of antibiotic resistance in bacterial pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeEnterotoxigenic Escherichia coliEscherichia coli InfectionsEscherichia coli VaccinesEscherichia coli ProteinsFimbriae ProteinsAnimalsMiceAdministration, OralVaccines, SubunitMice, Inbred BALB CFemaleDiarrheaVaccines, SyntheticGastrointestinal MicrobiomeAdhesins, Escherichia coli

Stichwörter der Autor:innen

F4+ ETECSaccharomyces cerevisiaeoral vaccine

Substanzen

Escherichia coli VaccinesVaccines, SubunitEscherichia coli ProteinsFaeG protein, E coliFimbriae ProteinsVaccines, SyntheticAdhesins, Escherichia coli

Autor:innen und Institutionen

  • National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan, China.
  • The Cooperative Innovation Centre for Sustainable Pig Production, Huazhong Agricultural University, Wuhan, China.
  • College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • College of Life Science and Technology, Huazhong Agricultural University, Wuhan, China.

ORCID-Profile: Dayue Hu, Xiangmin Li, Ping Qian

Zitieren

APA

Hu, D., Li, X., Duan, X., Yang, L., Luo, B., Wang, L., Hu, Z., Zhou, Y., & Qian, P. (2025). Recombinant Saccharomyces cerevisiae EBY100/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.01817-24

Vancouver

Hu D, Li X, Duan X, Yang L, Luo B, Wang L, et al. Recombinant Saccharomyces cerevisiae EBY100/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection. Applied and Environmental Microbiology. 2025. doi:10.1128/aem.01817-24

BibTeX
@article{Hu2025,
  author = {Hu, Dayue and Li, Xiangmin and Duan, Xiaochao and Yang, Liuyue and Luo, Baizhi and Wang, Linkang and Hu, Zihui and Zhou, Yang and Qian, Ping},
  title = {Recombinant Saccharomyces cerevisiae EBY100/pYD1-FaeG: a candidate for an oral subunit vaccine against F4+ ETEC infection},
  journal = {Applied and Environmental Microbiology},
  year = {2025},
  doi = {10.1128/aem.01817-24}
}
Kostenlos starten →